Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Frank Odds
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Chemicals & Drugs
Procedures
Concepts & Ideas
Physiology
Genes & Molecular Sequences
Sign-in to see full Profile
Network (preview)
46
Gow, Neil
30
Brown, Alistair
29
MacCallum, Donna
11
Jacobsen, Mette
10
Marichal, Patrick
9
Maiden, Martin
9
Tavanti, Arianna
9
Bates, Steven
9
Davidson, Amanda
8
Vanden Bossche, Hugo
8
Shaw, Duncan
7
Munro, Carol
6
Bertram, Gwyneth
6
Borgers, Marcel
5
Rinaldi, Michael
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Frank Odds (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Rodaki Alexandra; Bohovych Iryna M; Enjalbert Brice; Young Tim; Odds Frank C; Gow Neil A R; Brown Alistair J P
Glucose promotes stress resistance in the fungal pathogen Candida albicans.
Molecular biology of the cell 2009;20(22):4845-55.
-
2009: Calderone Richard; Odds Frank C; Boekhout Teun
Candida albicans: fundamental research on an opportunistic human pathogen.
FEMS yeast research 2009;9(7):971-2.
-
2009: Odds Frank C
In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1.
FEMS yeast research 2009;9(7):1091-101.
-
2009: Borman Andrew M; Linton Christopher J; Oliver Debra; Palmer Michael D; Szekely Adrien; Odds Frank C; Johnson Elizabeth M
Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis.
Journal of clinical microbiology 2009;47(7):2307-10.
-
2009: MacCallum Donna M; Castillo Luis; Nather Kerstin; Munro Carol A; Brown Alistair J P; Gow Neil A R; Odds Frank C
Property differences among the four major Candida albicans strain clades.
Eukaryotic cell 2009;8(3):373-87.
-
2009: Walker Louise A; Maccallum Donna M; Bertram Gwyneth; Gow Neil A R; Odds Frank C; Brown Alistair J P
Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney.
Fungal genetics and biology : FG & B 2009;46(2):210-9.
-
2009: MacCallum Donna M; Castillo Luis; Brown Alistair J P; Gow Neil A R; Odds Frank C
Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.
PloS one 2009;4(7):e6420.
-
2008: Jacobsen Mette D; Duncan Amanda D; Bain Judith; Johnson Elizabeth M; Naglik Julian R; Shaw Duncan J; Gow Neil A R; Odds Frank C
Mixed Candida albicans strain populations in colonized and infected mucosal tissues.
FEMS yeast research 2008;8(8):1334-8.
-
2008: Odds Frank C
Secreted proteinases and Candida albicans virulence.
Microbiology (Reading, England) 2008;154(Pt 11):3245-6.
-
2008: Jacobsen Mette D; Rattray Alexander M J; Gow Neil A R; Odds Frank C; Shaw Duncan J
Mitochondrial haplotypes and recombination in Candida albicans.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2008;46(7):647-54.
-
2008: Brand Alexandra; Barnes Julia D; Mackenzie Kevin S; Odds Frank C; Gow Neil A R
Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa.
FEMS microbiology letters 2008;287(1):48-55.
-
2008: Takakura Shunji; Ichiyama Satoshi; Bain Judith M; Davidson Amanda D; Jacobsen Mette D; Shaw Duncan J; Gow Neil A R; Odds Frank C
Comparison of Candida albicans strain types among isolates from three countries.
International journal of medical microbiology : IJMM 2008;298(7-8):663-8.
-
2008: Jacobsen Mette D; Boekhout Teun; Odds Frank C
Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.
FEMS yeast research 2008;8(5):764-70.
-
2008: Jacobsen Mette D; Bougnoux Marie-Elisabeth; d'Enfert Christophe; Odds Frank C
Multilocus sequence typing of Candida albicans isolates from animals.
Research in microbiology 2008;159(6):436-40.
-
2008: Odds Frank C; Jacobsen Mette D
Multilocus sequence typing of pathogenic Candida species.
Eukaryotic cell 2008;7(7):1075-84.
-
2008: Jacobsen Mette D; Davidson Amanda D; Li Shu-Ying; Shaw Duncan J; Gow Neil A R; Odds Frank C
Molecular phylogenetic analysis of Candida tropicalis isolates by multi-locus sequence typing.
Fungal genetics and biology : FG & B 2008;45(6):1040-2.
-
2008: Naglik Julian R; Fidel Paul L; Odds Frank C
Animal models of mucosal Candida infection.
FEMS microbiology letters 2008;283(2):129-39.
-
2008: Strijbis Karin; van Roermund Carlo W T; Visser Wouter F; Mol Els C; van den Burg Janny; MacCallum Donna M; Odds Frank C; Paramonova Ekaterina; Krom Bastiaan P; Distel Ben
Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation.
Eukaryotic cell 2008;7(4):610-8.
-
2008: Barelle Caroline J; Duncan Vanessa M S; Brown Alistair J P; Gow Neil A R; Odds Frank C
Azole antifungals induce up-regulation of SAP4, SAP5 and SAP6 secreted proteinase genes in filamentous Candida albicans cells in vitro and in vivo.
The Journal of antimicrobial chemotherapy 2008;61(2):315-22.
-
2007: Mora-Montes Héctor M; Bates Steven; Netea Mihai G; Díaz-Jiménez Diana F; López-Romero Everardo; Zinker Samuel; Ponce-Noyola Patricia; Kullberg Bart Jan; Brown Alistair J P; Odds Frank C; Flores-Carreón Arturo; Gow Neil A R
Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction.
Eukaryotic cell 2007;6(12):2184-93.
-
2007: Gow Neil A R; Netea Mihai G; Munro Carol A; Ferwerda Gerben; Bates Steven; Mora-Montes Héctor M; Walker Louise; Jansen Trees; Jacobs Liesbeth; Tsoni Vicky; Brown Gordon D; Odds Frank C; Van der Meer Jos W M; Brown Alistair J P; Kullberg Bart Jan
Immune recognition of Candida albicans beta-glucan by dectin-1.
The Journal of infectious diseases 2007;196(10):1565-71.
-
2007: Brown Alistair J P; Odds Frank C; Gow Neil A R
Infection-related gene expression in Candida albicans.
Current opinion in microbiology 2007;10(4):307-13.
-
2007: Odds Frank C; Hanson Mary F; Davidson Amanda D; Jacobsen Mette D; Wright Pauline; Whyte Julie A; Gow Neil A R; Jones Brian L
One year prospective survey of Candida bloodstream infections in Scotland.
Journal of medical microbiology 2007;56(Pt 8):1066-75.
-
2007: Odds Frank C; Bougnoux Marie-Elisabeth; Shaw Duncan J; Bain Judith M; Davidson Amanda D; Diogo Dorothée; Jacobsen Mette D; Lecomte Maud; Li Shu-Ying; Tavanti Arianna; Maiden Martin C J; Gow Neil A R; d'Enfert Christophe
Molecular phylogenetics of Candida albicans.
Eukaryotic cell 2007;6(6):1041-52.
-
2007: Bates Steven; de la Rosa José M; MacCallum Donna M; Brown Alistair J P; Gow Neil A R; Odds Frank C
Candida albicans Iff11, a secreted protein required for cell wall structure and virulence.
Infection and immunity 2007;75(6):2922-8.
-
2007: Bain J M; Tavanti A; Davidson A D; Jacobsen M D; Shaw D; Gow N A R; Odds F C
Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus.
Journal of clinical microbiology 2007;45(5):1469-77.
-
2007: Enjalbert Brice; MacCallum Donna M; Odds Frank C; Brown Alistair J P
Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans.
Infection and immunity 2007;75(5):2143-51.
-
2007: Jacobsen Mette D; Whyte Julie A; Odds Frank C
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
Antimicrobial agents and chemotherapy 2007;51(5):1882-4.
-
2007: Kunze Donika; MacCallum Donna; Odds Frank C; Hube Bernhard
Multiple functions of DOA1 in Candida albicans.
Microbiology (Reading, England) 2007;153(Pt 4):1026-41.
-
2007: Argimón Silvia; Wishart Jill A; Leng Roger; Macaskill Susan; Mavor Abigail; Alexandris Thomas; Nicholls Susan; Knight Andrew W; Enjalbert Brice; Walmsley Richard; Odds Frank C; Gow Neil A R; Brown Alistair J P
Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans.
Eukaryotic cell 2007;6(4):682-92.
-
2007: Jacobsen Mette D; Gow Neil A R; Maiden Martin C J; Shaw Duncan J; Odds Frank C
Strain typing and determination of population structure of Candida krusei by multilocus sequence typing.
Journal of clinical microbiology 2007;45(2):317-23.
-
2007: Chaves G M; Bates S; Maccallum D M; Odds F C
Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model.
Genetics and molecular research : GMR 2007;6(4):1051-63.
-
2006: Piekarska Katarzyna; Mol Els; van den Berg Marlene; Hardy Guy; van den Burg Janny; van Roermund Carlo; MacCallum Donna; Odds Frank; Distel Ben
Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans.
Eukaryotic cell 2006;5(11):1847-56.
-
2006: Odds F C; Davidson A D; Jacobsen M D; Tavanti A; Whyte J A; Kibbler C C; Ellis D H; Maiden M C J; Shaw D J; Gow N A R
Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.
Journal of clinical microbiology 2006;44(10):3647-58.
-
2006: MacCallum Donna M; Findon Helen; Kenny Claire C; Butler Geraldine; Haynes Ken; Odds Frank C
Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts.
Infection and immunity 2006;74(9):5244-8.
-
2006: Odds Frank C
Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
Current opinion in investigational drugs (London, England : 2000) 2006;7(8):766-72.
-
2006: Chen Kuo-Wei; Chen Yee-Chun; Lo Hsiu-Jung; Odds Frank C; Wang Tzu-Hui; Lin Chi-Yang; Li Shu-Ying
Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan.
Journal of clinical microbiology 2006;44(6):2172-8.
-
2006: Netea Mihai G; Gow Neil A R; Munro Carol A; Bates Steven; Collins Claire; Ferwerda Gerben; Hobson Richard P; Bertram Gwyneth; Hughes H Bleddyn; Jansen Trees; Jacobs Liesbeth; Buurman Ed T; Gijzen Karlijn; Williams David L; Torensma Ruurd; McKinnon Alistair; MacCallum Donna M; Odds Frank C; Van der Meer Jos W M; Brown Alistair J P; Kullberg Bart Jan
Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors.
The Journal of clinical investigation 2006;116(6):1642-50.
-
2006: Barelle Caroline J; Priest Claire L; Maccallum Donna M; Gow Neil A R; Odds Frank C; Brown Alistair J P
Niche-specific regulation of central metabolic pathways in a fungal pathogen.
Cellular microbiology 2006;8(6):961-71.
-
2006: Odds Frank
Antifungal combinations: where do we stand?
Thérapie 2006;61(3):249-50.
-
2006: Albrecht Antje; Felk Angelika; Pichova Iva; Naglik Julian R; Schaller Martin; de Groot Piet; Maccallum Donna; Odds Frank C; Schäfer Wilhelm; Klis Frans; Monod Michel; Hube Bernhard
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions.
The Journal of biological chemistry 2006;281(2):688-94.
-
2006: Bates Steven; Hughes H Bleddyn; Munro Carol A; Thomas William P H; MacCallum Donna M; Bertram Gwyneth; Atrih Abdelmadjid; Ferguson Michael A J; Brown Alistair J P; Odds Frank C; Gow Neil A R
Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans.
The Journal of biological chemistry 2006;281(1):90-8.
-
2005: Odds Frank C
Genomics, molecular targets and the discovery of antifungal drugs.
Revista iberoamericana de micología : órgano de la Asociación Española de Especialistas en Micología 2005;22(4):229-37.
-
2005: Tavanti Arianna; Davidson Amanda D; Fordyce Mark J; Gow Neil A R; Maiden Martin C J; Odds Frank C
Population structure and properties of Candida albicans, as determined by multilocus sequence typing.
Journal of clinical microbiology 2005;43(11):5601-13.
-
2005: Tavanti Arianna; Davidson Amanda D; Johnson Elizabeth M; Maiden Martin C J; Shaw Duncan J; Gow Neil A R; Odds Frank C
Multilocus sequence typing for differentiation of strains of Candida tropicalis.
Journal of clinical microbiology 2005;43(11):5593-600.
-
2005: Tournu Hélène; Tripathi Gyanendra; Bertram Gwyneth; Macaskill Susan; Mavor Abigail; Walker Louise; Odds Frank C; Gow Neil A R; Brown Alistair J P
Global role of the protein kinase Gcn2 in the human pathogen Candida albicans.
Eukaryotic cell 2005;4(10):1687-96.
-
2005: Kunze Donika; Melzer Inga; Bennett Désirée; Sanglard Dominique; MacCallum Donna; Nörskau Jan; Coleman David C; Odds Frank C; Schäfer Wilhelm; Hube Bernhard
Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans.
Microbiology (Reading, England) 2005;151(Pt 10):3381-94.
-
2005: MacCallum Donna M; Whyte Julie A; Odds Frank C
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
Antimicrobial agents and chemotherapy 2005;49(9):3697-701.
-
2005: Bates Steven; MacCallum Donna M; Bertram Gwyneth; Munro Carol A; Hughes H Bleddyn; Buurman Ed T; Brown Alistair J P; Odds Frank C; Gow Neil A R
Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence.
The Journal of biological chemistry 2005;280(24):23408-15.
-
2005: MacCallum Donna M; Odds Frank C
Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
Mycoses 2005;48(3):151-61.
-
2005: Copping Vanessa M S; Barelle Caroline J; Hube Bernhard; Gow Neil A R; Brown Alistair J P; Odds Frank C
Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.
The Journal of antimicrobial chemotherapy 2005;55(5):645-54.
-
2005: Fradin Chantal; De Groot Piet; MacCallum Donna; Schaller Martin; Klis Frans; Odds Frank C; Hube Bernhard
Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood.
Molecular microbiology 2005;56(2):397-415.
-
2005: Meerpoel Lieven; Backx Leo J J; Van der Veken Louis J E; Heeres Jan; Corens David; De Groot Alex; Odds Frank C; Van Gerven Frans; Woestenborghs Filip A A; Van Breda Andre; Oris Michel; van Dorsselaer Pascal; Willemsens Gustaaf H M; Vermuyten Karen J P; Marichal Patrick J M G; Vanden Bossche Hugo F; Ausma Jannie; Borgers Marcel
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
Journal of medicinal chemistry 2005;48(6):2184-93.
-
2005: Tavanti Arianna; Davidson Amanda D; Gow Neil A R; Maiden Martin C J; Odds Frank C
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.
Journal of clinical microbiology 2005;43(1):284-92.
-
2005: Munro Carol A; Bates Steven; Buurman Ed T; Hughes H Bleddyn; Maccallum Donna M; Bertram Gwyneth; Atrih Abdel; Ferguson Michael A J; Bain Judith M; Brand Alexandra; Hamilton Suzanne; Westwater Caroline; Thomson Lynn M; Brown Alistair J P; Odds Frank C; Gow Neil A R
Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence.
The Journal of biological chemistry 2005;280(2):1051-60.
-
2004: MacCallum Donna M; Odds Frank C
Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.
Antimicrobial agents and chemotherapy 2004;48(12):4911-4.
-
2004: Vanden Bossche Hugo; Ausma Jannie; Bohets Hilde; Vermuyten Karen; Willemsens Gustaaf; Marichal Patrick; Meerpoel Lieven; Odds Frank; Borgers Marcel
The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
Antimicrobial agents and chemotherapy 2004;48(9):3272-8.
-
2004: Hobson Richard P; Munro Carol A; Bates Steven; MacCallum Donna M; Cutler Jim E; Heinsbroek Sigrid E M; Brown Gordon D; Odds Frank C; Gow Neil A R
Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition.
The Journal of biological chemistry 2004;279(38):39628-35.
-
2004: MacCallum D M; Odds F C
Safety aspects of working with Candida albicans-infected mice.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2004;42(4):305-9.
-
2004: Brand Alexandra; MacCallum Donna M; Brown Alistair J P; Gow Neil A R; Odds Frank C
Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.
Eukaryotic cell 2004;3(4):900-9.
-
2004: Galán Amparo; Casanova Manuel; Murgui Amelia; MacCallum Donna M; Odds Frank C; Gow Neil A R; Martínez José P
The Candida albicans pH-regulated KER1 gene encodes a lysine/glutamic-acid-rich plasma-membrane protein that is involved in cell aggregation.
Microbiology (Reading, England) 2004;150(Pt 8):2641-51.
-
2004: Kelly Mary T; MacCallum Donna M; Clancy Susanne D; Odds Frank C; Brown Alistair J P; Butler Geraldine
The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence.
Molecular microbiology 2004;53(3):969-83.
-
2004: Tavanti Arianna; Gow Neil A R; Maiden Martin C J; Odds Frank C; Shaw Duncan J
Genetic evidence for recombination in Candida albicans based on haplotype analysis.
Fungal genetics and biology : FG & B 2004;41(5):553-62.
-
2004: Barelle Caroline J; Manson Claire L; MacCallum Donna M; Odds Frank C; Gow Neil A R; Brown Alistair J P
GFP as a quantitative reporter of gene regulation in Candida albicans.
Yeast (Chichester, England) 2004;21(4):333-40.
-
2004: Odds F; Ausma J; Van Gerven F; Woestenborghs F; Meerpoel L; Heeres J; Vanden Bossche H; Borgers M
In vitro and in vivo activities of the novel azole antifungal agent r126638.
Antimicrobial agents and chemotherapy 2004;48(2):388-91.
-
2004: Sendid Boualem; Jouault Thierry; Coudriau Richard; Camus Daniel; Odds Frank; Tabouret Marc; Poulain Daniel
Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis.
Journal of clinical microbiology 2004;42(1):164-71.
-
2004: Odds Frank C; Brown Alistair J P; Gow Neil A R
Candida albicans genome sequence: a platform for genomics in the absence of genetics.
Genome biology 2004;5(7):230.
-
2003: Bougnoux M-E; Tavanti A; Bouchier C; Gow N A R; Magnier A; Davidson A D; Maiden M C J; D'Enfert C; Odds F C
Collaborative consensus for optimized multilocus sequence typing of Candida albicans.
Journal of clinical microbiology 2003;41(11):5265-6.
-
2003: Odds Frank
Professor Emly Glyn Vaughan Evans 4th October 1941-4th August 2003.
The Journal of antimicrobial chemotherapy 2003;52(4):537.
-
2003: Tavanti Arianna; Gow Neil A R; Senesi Sonia; Maiden Martin C J; Odds Frank C
Optimization and validation of multilocus sequence typing for Candida albicans.
Journal of clinical microbiology 2003;41(8):3765-76.
-
2003: Bartizal C; Odds F C
Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
Antimicrobial agents and chemotherapy 2003;47(7):2100-7.
-
2003: Odds Frank C; Brown Alistair J P; Gow Neil A R
Antifungal agents: mechanisms of action.
Trends in microbiology 2003;11(6):272-9.
-
2003: Odds Frank C
Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):1229-31.
-
2003: Odds F C
Reflections on the question: what does molecular mycology have to do with the clinician treating the patient?
Medical mycology : official publication of the International Society for Human and Animal Mycology 2003;41(1):1-6.
-
2002: MacCallum Donna M; Odds Frank C
Efficacy of parenteral itraconazole against disseminated Candida albicans infection in two mouse strains.
The Journal of antimicrobial chemotherapy 2002;50(2):225-9.
-
2002: MacCallum Donna M; Odds Frank C
Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs.
The Journal of antimicrobial chemotherapy 2002;50(2):219-24.
-
2002: Gow Neil A R; Brown Alistair J P; Odds Frank C
Fungal morphogenesis and host invasion.
Current opinion in microbiology 2002;5(4):366-71.
-
2002: Sanglard Dominique; Odds Frank C
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
The Lancet infectious diseases 2002;2(2):73-85.
-
2001: Murad A M; Leng P; Straffon M; Wishart J; Macaskill S; MacCallum D; Schnell N; Talibi D; Marechal D; Tekaia F; d'Enfert C; Gaillardin C; Odds F C; Brown A J
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans.
The EMBO journal 2001;20(17):4742-52.
-
2001: Rambali B; Fernandez J A; Van Nuffel L; Woestenborghs F; Baert L; Massart D L; Odds F C
Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables.
The Journal of antimicrobial chemotherapy 2001;48(2):163-77.
-
2001: Odds F C; Gow N A; Brown A J
Fungal virulence studies come of age.
Genome biology 2001;2(3):REVIEWS1009.
-
2000: Saha A K; Liu L; Marichal P; Odds F
Novel antifungals based on 4-substituted imidazole: solid-phase synthesis of substituted aryl sulfonamides towards optimization of in vitro activity.
Bioorganic & medicinal chemistry letters 2000;10(24):2735-9.
-
2000: Odds F C; Davidson A
"Room temperature" use of CHROMagar Candida.
Diagnostic microbiology and infectious disease 2000;38(3):147-50.
-
2000: Odds F C; Oris M; Van Dorsselaer P; Van Gerven F
Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections.
Antimicrobial agents and chemotherapy 2000;44(11):3180-3.
-
2000: Saha A K; Liu L; Simoneaux R L; Kukla M J; Marichal P; Odds F
Novel antifungals based on 4-substituted imidazole: a combinatorial chemistry approach to lead discovery and optimization.
Bioorganic & medicinal chemistry letters 2000;10(19):2175-8.
-
2000: Odds F C; Van Nuffel L; Gow N A
Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host.
Microbiology (Reading, England) 2000;146 ( Pt 8)():1881-9.
-
2000: Gow N A; Brown A J; Odds F C
Candida's arranged marriage.
Science (New York, N.Y.) 2000;289(5477):256-7.
-
2000: Odds F C
Pathogenic fungi in the 21st century.
Trends in microbiology 2000;8(5):200-1.
-
2000: Odds F C; Bossche H V
Antifungal activity of itraconazole compared with hydroxy-itraconazole in vitro.
The Journal of antimicrobial chemotherapy 2000;45(3):371-3.
-
2000: Odds F C; Brown A J; Gow N A
Might Candida albicans be made to mate after all?
Trends in microbiology 2000;8(1):4-6.
-
1999: Marichal P; Gorrens J; Laurijssens L; Vermuyten K; Van Hove C; Le Jeune L; Verhasselt P; Sanglard D; Borgers M; Ramaekers F C; Odds F; Vanden Bossche H
Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.
Antimicrobial agents and chemotherapy 1999;43(11):2663-70.
-
1999: Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers F C; Odds F C; Bossche H V
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
Microbiology (Reading, England) 1999;145 ( Pt 10)():2701-13.
-
1998: Odds F C; Van Nuffel L; Dams G
Prevalence of Candida dubliniensis isolates in a yeast stock collection.
Journal of clinical microbiology 1998;36(10):2869-73.
-
1998: Buurman E T; Westwater C; Hube B; Brown A J; Odds F C; Gow N A
Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7670-5.
-
1998: Odds F C; Van Gerven F; Espinel-Ingroff A; Bartlett M S; Ghannoum M A; Lancaster M V; Pfaller M A; Rex J H; Rinaldi M G; Walsh T J
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Antimicrobial agents and chemotherapy 1998;42(2):282-8.
-
1997: Marichal P; Vanden Bossche H; Odds F C; Nobels G; Warnock D W; Timmerman V; Van Broeckhoven C; Fay S; Mose-Larsen P
Molecular biological characterization of an azole-resistant Candida glabrata isolate.
Antimicrobial agents and chemotherapy 1997;41(10):2229-37.
-
1997: Odds F C
Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes?
Revista iberoamericana de micología : órgano de la Asociación Española de Especialistas en Micología 1997;14(3):83-4.
-
1997: Hube B; Sanglard D; Odds F C; Hess D; Monod M; Schäfer W; Brown A J; Gow N A
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence.
Infection and immunity 1997;65(9):3529-38.
-
1997: Rex J H; Pfaller M A; Galgiani J N; Bartlett M S; Espinel-Ingroff A; Ghannoum M A; Lancaster M; Odds F C; Rinaldi M G; Walsh T J; Barry A L
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):235-47.
-
1997: Odds F C; Rinaldi M G; Cooper C R; Fothergill A; Pasarell L; McGinnis M R
Candida and Torulopsis: a blinded evaluation of use of pseudohypha formation as basis for identification of medically important yeasts.
Journal of clinical microbiology 1997;35(1):313-6.
-
1997: Espinel-Ingroff A; Bartlett M; Bowden R; Chin N X; Cooper C; Fothergill A; McGinnis M R; Menezes P; Messer S A; Nelson P W; Odds F C; Pasarell L; Peter J; Pfaller M A; Rex J H; Rinaldi M G; Shankland G S; Walsh T J; Weitzman I
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
Journal of clinical microbiology 1997;35(1):139-43.
-
1996: Odds F C; Dams G; Just G; Lewi P
Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth.
Antimicrobial agents and chemotherapy 1996;40(3):588-94.
-
1996: Odds F C
Resistance of clinically important yeasts to antifungal agents.
International journal of antimicrobial agents 1996;6(3):145-7.
-
1996: Odds F C
Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects.
International journal of antimicrobial agents 1996;6(3):141-4.
-
1995: Van Gerven F; Odds F C
The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.
Mycoses 1995;38(9-10):389-93.
-
1995: Odds F C; Vranckx L; Woestenborghs F
Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
Antimicrobial agents and chemotherapy 1995;39(9):2051-60.
-
1995: Odds F C; De Backer T; Dams G; Vranckx L; Woestenborghs F
Oxygen as limiting nutrient for growth of Cryptococcus neoformans.
Journal of clinical microbiology 1995;33(4):995-7.
-
1994: Vanden Bossche H; Marichal P; Odds F C
Molecular mechanisms of drug resistance in fungi.
Trends in microbiology 1994;2(10):393-400.
-
1994: Odds F C
Pathogenesis of Candida infections.
Journal of the American Academy of Dermatology 1994;31(3 Pt 2):S2-5.
-
1994: Odds F C; Bernaerts R
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
Journal of clinical microbiology 1994;32(8):1923-9.
-
1994: Vanden Bossche H; Warnock D W; Dupont B; Kerridge D; Sen Gupta S; Improvisi L; Marichal P; Odds F C; Provost F; Ronin O
Mechanisms and clinical impact of antifungal drug resistance.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32 Suppl 1():189-202.
-
1994: Odds F C
Candida albicans, the life and times of a pathogenic yeast.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32 Suppl 1():1-8.
-
1993: Odds F C
Effects of temperature on anti-Candida activities of antifungal antibiotics.
Antimicrobial agents and chemotherapy 1993;37(4):685-91.
-
1993: Odds F C
Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
Journal of dermatological science 1993;5(2):65-72.
-
1992: vanden Bossche H; Marichal P; Odds F C; Le Jeune L; Coene M C
Characterization of an azole-resistant Candida glabrata isolate.
Antimicrobial agents and chemotherapy 1992;36(12):2602-10.
-
1992: Odds F C
Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.
Antimicrobial agents and chemotherapy 1992;36(8):1727-37.
-
1992: Xhonneux B; Jansen T; Borgers M; Odds F C
Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs.
The Journal of antimicrobial chemotherapy 1992;30(2):181-8.
-
1992: Odds F C; Arai T; Disalvo A F; Evans E G; Hay R J; Randhawa H S; Rinaldi M G; Walsh T J
Nomenclature of fungal diseases: a report and recommendations from a Sub-Committee of the International Society for Human and Animal Mycology (ISHAM).
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(1):1-10.
-
1991: Odds F C
Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts.
Journal of clinical microbiology 1991;29(12):2735-40.
-
1991: Van Cutsem J; Van Gerven F; Cauwenbergh G; Odds F; Janssen P A
The antiinflammatory effects of ketoconazole. A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs.
Journal of the American Academy of Dermatology 1991;25(2 Pt 1):257-61.
-
1991: Hube B; Turver C J; Odds F C; Eiffert H; Boulnois G J; Köchel H; Rüchel R
Sequence of the Candida albicans gene encoding the secretory aspartate proteinase.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1991;29(2):129-32.
-
1991: Hube B; Turver C J; Odds F C; Eiffert H; Boulnois G J; Köchel H; Rüchel R
[Identification, cloning and characterization of the gene for the secretory aspartate protease of Candida albicans]
Mycoses 1991;34 Suppl 1():59-61.
-
1991: Odds F C
Long-term laboratory preservation of pathogenic yeasts in water.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1991;29(6):413-5.
-
1991: Odds F C
Sabouraud('s) agar.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1991;29(6):355-9.
Sign-in to see more